Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS) header
Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS) profile picture

Director of Medical Services at Medipal International Hospital Clinical Physiologist NCDs • Building scalable clinical systems

Kampala
Joined March 2023
Photo by Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS)Photo by Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS)Photo by Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS)Photo by Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS)Photo by Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS)Photo by Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS)Photo by Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS)Photo by Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS)Photo by Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS)Photo by Abdul M. Ssekandi, MBChB, MSc., M.A.P.S (@JC_by_AMS)
Early metformin looked favorable in a secondary reanalysis of 526 gestational-diabetes pregnancies (win ratio 1.46), mainly through less insulin initiation. The original primary composite was neutral, so this is not a new definitive trial result. doi.org/10.1001/jamanetworko…
24
Abdul M. Ssekandi, MBChB, MSc., M.A.P.S retweeted
🔥 Two more Dissertations added to the master shelf. 🔥 Congratulations @kiconco_ritah on your PhD @MbararaUST 🔥 Congratulations Dr Mawanda Abdul Nasser upon completion in of MSc Physiology @Makerere @JC_by_AMS @MirembeDr @SemitalaFred
3
12
59
2,448
Before adopting an innovation, hospitals should ask: Does it improve a patient outcome? Can our workflow deliver it reliably? What will we stop doing to fund it? A better biomarker, alert or device matters only when the care pathway converts it into benefit.
1
71
A paediatric obesity trial crossed a clinically important threshold: BMI fell 18.5% with tirzepatide vs rose 0.5% with placebo at 72 weeks. SURMOUNT-ADOLESCENTS randomized 160 participants; GI events were common. Long-term safety still matters. doi.org/10.1001/jama.2026.23…
30
Deprescribing improved only while stewardship was active. In 4,827 older inpatients across 6 hospitals, an EHR Drug Burden Index plus pharmacist support increased deprescribing by 5.3 points—then gains faded. Alerts alone are not implementation. doi.org/10.1001/jamainternme…
1
27
Culturally adapted Caring Contacts did not outperform enhanced usual care. Among 709 American Indian/Alaska Native adults with active suicidality, both groups improved; only 64% had 12-month data. Negative trials should refine community-led care. doi.org/10.1001/jamanetworko…
31
A useful test for any hospital innovation: What outcome should change, by how much, and by when? Then ask who owns implementation after the trial team leaves. Evidence on deprescribing, diagnostics and AI points to the same lesson: workflow determines whether tools become care.
59
An open-source AI “co-scientist” completed five biomedical analyses with externally testable findings. Roberts et al. report speed and auditability, not better patient outcomes. Hospitals need validation, governance and secure data before clinical use. doi.org/10.1038/s41591-026-0…
2
72
Five days of 40-Hz brain stimulation improved consciousness scores more than 4-Hz or sham in a randomized trial of prolonged disorders of consciousness. Promising neurophysiology; one short study cannot establish routine rehabilitation benefit. sciencedirect.com/science/ar…
1
72
Rituximab added no proteinuria or kidney-function benefit in IgA nephropathy. RITA randomized 106 adults already receiving optimized renin–angiotensin blockade; 12-month proteinuria was similar. A negative trial can prevent costly therapeutic drift. ajkd.org/article/S0272-6386(…
59
Post-hospital mobility did not improve with booklets, videos, staff training and ward posters. INTOMOB randomized 383 older adults across 12 Swiss ward clusters; the 30-day difference was 0.67 points. Low-intensity education alone may be insufficient. doi.org/10.1001/jamanetworko…
56